MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 128879 | Name: ESK-001

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ESK-001 is a potent TYK2 inhibitor for immune-mediated diseases like plaque psoriasis and SLE. By targeting the TYK2 JH2 domain.

Chemical Structure

ESK-001
ESK-001
CAS#N/A

Theoretical Analysis

MedKoo Cat#: 128879

Name: ESK-001

CAS#: N/A

Chemical Formula: C22H18D6N6O3

Exact Mass: 426.2286

Molecular Weight: 426.23

Elemental Analysis: C, 61.95; H, 7.09; N, 19.70; O, 11.25

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
ESK-001; ESK001; ESK 001
IUPAC/Chemical Name
N-(4-((2-methoxy-3-(1-(methyl-d3)-1H-1,2,4-triazol-3-yl)phenyl)amino)-5-(propanoyl-3,3,3-d3)pyridin-2-yl)cyclopropanecarboxamide
InChi Key
FKCATCQHVCOBCX-WFGJKAKNSA-N
InChi Code
InChI=1S/C22H24N6O3/c1-4-18(29)15-11-23-19(26-22(30)13-8-9-13)10-17(15)25-16-7-5-6-14(20(16)31-3)21-24-12-28(2)27-21/h5-7,10-13H,4,8-9H2,1-3H3,(H2,23,25,26,30)/i1D3,2D3
SMILES Code
[2H]C([2H])([2H])N1N=C(C2=C(OC)C(NC3=CC(NC(C4CC4)=O)=NC=C3C(CC([2H])([2H])[2H])=O)=CC=C2)N=C1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 426.23 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Ucpinar S, Kwan JK, Hoffman JD, Tilley MK, Douglas JA, Rubio RG, Lu R, Nunn PA, Langrish CL. Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral allosteric TYK2 inhibitor ESK-001 using a randomized, double-blind, placebo-controlled study design. Clin Transl Sci. 2024 Dec;17(12):e70094. doi: 10.1111/cts.70094. PMID: 39604226; PMCID: PMC11602527. 2: Deng L, Wan L, Liao T, Wang L, Wang J, Wu X, Shi J. Recent progress on tyrosine kinase 2 JH2 inhibitors. Int Immunopharmacol. 2023 Aug;121:110434. doi: 10.1016/j.intimp.2023.110434. Epub 2023 Jun 12. PMID: 37315371. 3: Loo WJ, Turchin I, Prajapati VH, Gooderham MJ, Grewal P, Hong CH, Sauder M, Vender RB, Maari C, Papp KA. Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway. J Cutan Med Surg. 2023 Jan-Feb;27(1_suppl):3S-24S. doi: 10.1177/12034754221141680. Epub 2022 Dec 15. PMID: 36519621.